GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (OTCPK:CHJTF) » Definitions » Valuation Rank

CSPC Pharmaceutical Group (CSPC Pharmaceutical Group) Valuation Rank


View and export this data going back to . Start your Free Trial

What is CSPC Pharmaceutical Group Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

CSPC Pharmaceutical Group Valuation Rank Related Terms

Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

CSPC Pharmaceutical Group (CSPC Pharmaceutical Group) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (OTCPK:CHJTF) » Definitions » Valuation Rank
Comparable Companies
HKSE:01666 HKSE:01643 LLY JNJ MRK ABBV LSE:AZN XSWX:NOVN XSWX:ROG AMGN PFE XPAR:SAN BMY LSE:GSK GILD TSE:4568 TSE:4519 SHSE:600276 BIIB XTER:BAYN
Traded in Other Exchanges
CSPCY:USA 01093:Hong Kong CVG:Germany
Address
No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035
Website
https://www.cspc.com.hk
CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.